Efficacy of oral rifampicin in chronic central serous chorioretinopathy

被引:9
作者
Venkatesh, Ramesh [1 ]
Agarwal, Manisha [1 ]
Kantha, Meha [1 ]
机构
[1] Dr Shroffs Charity Eye Hosp, 5027 Kedarnath Rd, New Delhi 110002, India
来源
THERAPEUTIC ADVANCES IN OPHTHALMOLOGY | 2018年 / 10卷
关键词
antitubercular; central serous chorioretinopathy; chronic; rifampicin; subretinal fluid;
D O I
10.1177/2515841418807130
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Objective: To evaluate the role of oral rifampicin in the management of chronic central serous chorioretinopathy. Methods: Retrospective analysis of patients diagnosed with chronic central serous chorioretinopathy (duration >3 months) and treated with oral rifampicin 600 mg daily for a maximum period of 3 months was carried out. Baseline visual acuity, fundus fluorescein angiography, and optical coherence tomography were recorded and the patients were followed up. Resolution of subretinal fluid and improvement in visual acuity were the main outcome measures. Recurrence of subretinal fluid was noted. Any adverse reaction to the drug was monitored. Results: Nine eyes of eight patients were included in the study. The average age of the patients was 41.90 years (range 32-52 years). Mean duration of symptoms was 16 months (range 3-60 months). Mean duration of follow-up was 10.11 months (range 3-33 months). Fluorescein angiography showed four eyes with subfoveal leaks and five eyes with diffuse retinal pigment epitheliopathy. Complete resolution of subretinal fluid was achieved in four of the nine eyes - two patients at the end of 1 month, one patient each at the end of 2 and 3 months, respectively. Visual acuity improvement was noted in four of the nine eyes. Three patients had one-line improvement and one patient had a two-line visual improvement. None of the patients had severe adverse events for which the drug had to be discontinued. None of the patients had recurrence of subretinal fluid after the discontinuation of the drug. Conclusion: Oral rifampicin could provide a useful, effective, and cost-effective alternative for treatment of patients with chronic central serous choroidopathy and evidence of healthier retinal pigment epithelium, those with focal leakage. It was not effective in eyes with diffuse retinal pigment epitheliopathy.
引用
收藏
页数:6
相关论文
共 11 条
  • [1] Long-term macular function in eyes with central serous chorioretinopathy
    Baran, NV
    Gürlü, VP
    Esgin, H
    [J]. CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2005, 33 (04) : 369 - 372
  • [2] Half-dose verteporfin photodynamic therapy for acute central serous chorioretinopathy - One-year results of a randomized controlled trial
    Chan, Wai-Man
    Lai, Timothy Y. Y.
    Lai, Ricky Y. K.
    Liu, David T. L.
    Lam, Dennis S. C.
    [J]. OPHTHALMOLOGY, 2008, 115 (10) : 1756 - 1765
  • [3] Endogenous cortisol profile in patients with central serous chorioretinopathy
    Garg, SP
    Dada, T
    Talwar, D
    Biswas, NR
    [J]. BRITISH JOURNAL OF OPHTHALMOLOGY, 1997, 81 (11) : 962 - 964
  • [4] Khan Perwez, 2017, BMJ Case Rep, V2017, DOI 10.1136/bcr-2016-216471
  • [5] INTRAVITREAL BEVACIZUMAB INJECTION FOR CENTRAL SEROUS CHORIORETINOPATHY
    Lim, Su Jin
    Roh, Mi In
    Kwon, Oh Woong
    [J]. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2010, 30 (01): : 100 - 106
  • [6] Ma J, 2014, ACTA OPHTHALMOL, pe594
  • [7] Nelson Joel, 2014, Retin Cases Brief Rep, V8, P70, DOI 10.1097/ICB.0000000000000007
  • [8] Ravage Zac B, 2012, Retin Cases Brief Rep, V6, P129, DOI 10.1097/ICB.0b013e3182235561
  • [9] COMPARISON OF EFFICACY AND SAFETY BETWEEN HALF-FLUENCE AND FULL-FLUENCE PHOTODYNAMIC THERAPY FOR CHRONIC CENTRAL SEROUS CHORIORETINOPATHY
    Shin, Joo Young
    Woo, Se Joon
    Yu, Hyeong Gon
    Park, Kyu Hyung
    [J]. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2011, 31 (01): : 119 - 126
  • [10] Oral Rifampin treatment for longstanding chronic central serous chorioretinopathy
    Shulman, Shiri
    Goldenberg, Dafna
    Schwartz, Roy
    Habot-Wilner, Zohar
    Barak, Adiel
    Ehrlich, Nurit
    Loewenstein, Anat
    Goldstein, Michaella
    [J]. GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2016, 254 (01) : 15 - 22